Shift Work: A Risk Factor for Central Serous

Chorioretinopathy

ELODIE BOUSQUET, MYRIAM DHUNDASS, MATHIEU LEHMANN, PIERRE-RAPHAEL ROTHSCHILD,

VIRGINIE BAYON, DAMIEN LEGER, CIARA BERGIN, ALI DIRANI, TALAL BEYDOUN, AND
FRANCINE BEHAR-COHEN

PURPOSE: To investigate if shift work or sleep distur- and focal serous detachments of the neurosensory retina
bances are risk factors for central serous chorioretinop- and retinal pigment epithelium alterations. The role of
athy (CSCR). choroid hyperpermeability in the pathogenesis of CSCR

DESIGN: Prospective case-control study. has been well documented recently with multimodal imag-

METHODS: Forty patients with active CSCR and 40 ing modalities.2 In CSCR patients, a thick choroid has
controls (age- and sex-matched) were prospectively been reported not only in the affected eye but also in the
recruited from the Ophthalmology Department of Hotel fellow eye, which is consistent with bilateral choroidal
Dieu Hospital, Paris, between November 2013 and hyperpermeability.2,3
December 2014. All patients were asked to complete a To date, several risk factors for CSCR have been
questionnaire addressing previously described risk factors identified,3 and the most consistent is corticosteroid
and working hours, as well as the Insomnia Severity exposure from therapeutic administration or from endog-
Index (ISI), a validated instrument for assessing sleep enous overproduction, as in Cushing syndrome.46
disturbances. Corticosteroids were recently shown to induce

RESULTS: The mean age of the CSCR group was 44 9 choroidal vasodilation through mineralocorticoid
years, whereas the mean age of the control group was receptor activation in animal models.3 CSCR has also
43 10 years. By use of multivariate analysis, shift been associated with increased sympathetic activity7
work (odds ratio [OR] [95% confidence interval]: 5 and sympathomimetic medication.8 Psychological stress9
[1.220.4]; P [ .02), steroid use (OR: 5.5 [1.126.2]; and type A personality10 with narcissistic traits11
P [ .03), and recent psychological stress (OR: have also been identified as contributing factors.
15.3 [4.154.5]; P < .001) were found to be indepen- Additional associations have been reported with hyper-
dently associated with CSCR. tension, coronary heart disease, peptic ulcer disease,

CONCLUSION: The outcomes of this study suggest that antihistamines, antibiotics, and psychopharmacologic
shift work is an independent risk factor of CSCR. Further medications.6,12
studies are required to confirm these results and to Shift work includes work hours that fall outside the
examine if work reconversion would be beneficial in the standard daylight hours (7 AM to 6/7 PM),13 including
treatment of patients with chronic/recurrent evening, night, morning, rotating, and irregular shifts.14
CSCR. (Am J Ophthalmol 2016;165:2328. 2016 In industrialized countries, 15%20% of the work force
Elsevier Inc. All rights reserved.) have regular shift work.1315 It leads to circadian
misalignment and sleep disturbances that have been
associated with increased risk of obesity, diabetes,

C
ENTRAL SEROUS CHORIORETINOPATHY (CSCR) IS A
cardiovascular disease, depression, and cancer.16,17
chorioretinal disease that most often affects
Mechanisms underlying these health problems are not
middle-aged men.1 It is characterized by posterior
fully elucidated but are thought to be related to sleep and
circadian disruption.14 Indeed, sleep disturbances have
Supplemental Material available at AJO.com. been associated with increased activities of the
Accepted for publication Feb 15, 2016. hypothalamic-pituitary adrenal axis and the autonomic
From the Department of Ophthalmology (E.B., M.D., M.L., P.-R.R., sympathoadrenal system, characterized by altered secretion
T.B.) and Sleep and Vigilance Center (V.B., D.L.), Hotel-Dieu of Paris,
Assistance Publique-Hopitaux de Paris, AP-HP, Paris, France, of cortisol and catecholamine hormones.18
Universite Sorbonne Paris Cite, Paris, France; Inserm U1138, Team 17, Since CSCR patients have higher levels of urine and
Universite Sorbonne Paris Cite, Universite Pierre et Marie Curie,
Centre de Recherche des Cordeliers, Paris, France (E.B., P.-R.R., F.B.-
plasma cortisol compared with the control group 19,20
C.); and Department of Ophthalmology University of Lausanne, Jules and increased levels of plasma catecholamines,21 we
Gonin Ophthalmic Hospital, Fondation Asile des Aveugles, Lausanne, questioned whether shift work and/or sleep disturbance
Switzerland (C.B., A.D., F.B.-C.).
Inquiries to Elodie Bousquet, Hopital Hotel Dieu, 1 Parvis Notre Dame, evaluated by the Insomnia Severity Index (ISI) could
75004 Paris, France; e-mail: [email protected] be risk factors for CSCR.

0002-9394/$36.00 2016 ELSEVIER INC. ALL RIGHTS RESERVED. 23

http://dx.doi.org/10.1016/j.ajo.2016.02.012
 METHODS
TABLE 1. Univariate Risk Factors for Central Serous

STUDY PATIENTS: Patients were prospectively included Chorioretinopathy
between November 4, 2013 and December 31, 2014 at
Control 95%
the Department of Ophthalmology in the Hotel Dieu Hos- Patients With Patients Odds Confidence
pital, Paris, France. The Ethics Committee of the French Exposure CSCR (n 40) (n 40) Ratio Interval P Value

Society of Ophthalmology approved this study. Informed Age, years 44.1 6 8.6 43 6 10.1 - - .6
signed consent was obtained from all subjects in compli- (mean 6 SD)
ance with the tenets of the Helsinki agreement. Male (%) 85 85 - - 1
Patients of working age between 20 and 60 years and Sleep disorders 23 (57.5%) 6 (15%) 7.6 2.721.7 <.001
presenting symptoms of CSCR were enrolled. Active (ISI >10), n (%)
CSCR was defined as a localized serous retinal detachment Shift work, n (%) 17 (42.5%) 6 (15%) 4.6 1.511.9 .007
on optical coherence tomography associated with angio- Steroid use, 15 (37.5%) 4 (10%) 5.4 1.717.3 .007
graphic leakage on fluorescein angiography without signs n (%)
Stress, n (%) 27 (67.5%) 5 (12.5%) 14.5 4.844.1 <.001
of choroidal neovascularization, polypoidal choroidal
Hypertension, 9 (22.5%) 3 (7.5%) 3.6 0.9613.3 .06
vasculopathy, or inflammation. Chronic CSCR was defined
n (%)
by the persistence of serous retinal detachment (SRD) for Depression, n (%) 7 (17.5%) 9 (22.5%) 0.7 0.22.1 .6
more than 6 months and/or with recurrent SRD associated Allergic disease, 13 (32.5%) 14 (35%) 0.9 0.42.2 .8
with widespread decompensation of the retinal pigment n (%)
epithelium.22 Tobacco use, 17 (42.5%) 12 (30%) 1.7 0.74.3 .2
Control patients were matched for age and sex at a ratio n (%)
of 1:1 and recruited at the emergency consultation with Alcohol use, 6 (15%) 4 (10%) 1.6 0.45.8 .5
ocular complaint but with no previous or ongoing retinal n (%)
pathology. The frequency of diseases including conjuncti-
CSCR central serous chorioretinopathy; ISI insomnia
vitis, blepharitis, chalazion, dry eye, keratitis, anterior
severity index.
uveitis, refractive disorders, vitreous floaters, eye contu-
sion, endophthalmitis, and migraine could not exceed
10% of the whole sample.
off score of 10 has been previously selected to detect
insomnia (86.1% sensitivity and 87.7% specificity).17

STUDY PROTOCOL: All patients were asked to complete
study questionnaires, which included an ISI questionnaire
STATISTICAL ANALYSIS: The data obtained were
in addition to questions addressing previously identified analyzed with independent t test or Mann-Whitney test for
risk factors such as history of systemic diseases (hyperten- continuous variables. Categorical variables were compared
sion, depression, allergic disease), current medication (cur- using x2 or Fisher exact test. Risk factors were initially
rent or recent [<3 months] corticosteroid intake [oral, analyzed using univariate linear regression analysis. Those
intranasal, inhalational, topical skin application, intrave- with statistical significance on univariate analysis were
nous, intramuscular, eye drop]), and degree of alcohol or included in multivariate analysis using logistic regression
tobacco use. Recent psychological stresses including life with forward stepwise selection (stepAIC, MASS package).
changes (death, divorce, familial strife, layoff) and stress Statistical analyses were performed with R version 3.1.3 (R
at work were also assessed. Participants provided informa- foundation of Statistical Computing, Vienna, Austria). A
tion on present and past (<1 year) working hours. Shift P value of less than .05 was considered significant.
work was defined as work starting before 7:00 AM or finish-
ing after 7:00 PM, and thus included evening, night, or
early morning working within this broader schema.
RESULTS

INSOMNIA SEVERITY INDEX: Sleep disturbances were
PATIENT CHARACTERISTICS: A total of 40 CSCR
evaluated using the ISI, which is a widely used instrument patients were compared with 40 sex- and age-matched con-
for evaluating insomnia symptoms and severity.23 The ISI trol patients (Table 1). The mean age (6 standard devia-
is a 7-item self-report questionnaire assessing the severity tion [SD]) of the CSCR group was 44.1 6 8.6 years,
of sleep onset, sleep maintenance, early-morning awak- whereas the mean age of the control group was 43 6 10.1
ening problems, sleep dissatisfaction, interference of sleep years (P .6). Both the CSCR and the control groups
difficulties with daytime functioning, noticeability of sleep were composed of 34 male (85%) and 6 female patients
problems by others, and distress caused by the sleep diffi- (15%), with a male-to-female ratio of 5.6:1.
culties, with a total score ranging from 0 to 28 In the CSCR group, 26 patients (65%) had an acute form
(Supplementary Material, available at AJO.com).17 A cut- of the disease and 14 patients (35%) had a chronic CSCR,

24 AMERICAN JOURNAL OF OPHTHALMOLOGY MAY 2016

FIGURE. Insomnia Severity Index (ISI) score obtained in central serous chorioretinopathy (CRSC) and control group. (Left) The
mean of the ISI score was significantly higher in the CSCR group (9.6 6.2) than in the control group (4.1 4.5; P < .001). (Right)
ISI score was higher in the CSCR group than in the control group for ISI 1A, ISI 1B, ISI 1C, ISI 2, ISI 3, and ISI 5. The ISI score
comprises 7 items assessing the severity of sleep onset (ISI 1A), sleep maintenance (ISI 1B), early-morning awakening problems (ISI
1C), sleep dissatisfaction (ISI 2), interference of sleep difficulties with daytime functioning (ISI 3), noticeability of sleep problems by
others (ISI 4), and distress caused by the sleep difficulties (ISI 5).

defined by the persistence of the SRD for more than Recent psychological stress was reported in 27 CSCR
6 months and/or with recurrent SRD associated with bilat- patients (67.5%) and in 5 control patients (12.5%;
eral widespread retinal pigment epithelium alterations.22 P < .001; OR: 14.5 [4.844.1], Table 1). Among the 27
CSCR patients, 14 patients reported stressful life changes

UNIVARIATE ANALYSIS: Previously reported risk factors, (death, disease, divorce, familial strife, layoff) and 13
sleep disturbance, and shift work were first analyzed with patients reported stress at work. The 5 control patients
univariate analysis (Table 1). reported work-related stress.
Sleep disturbances evaluated with the ISI questionnaire Other previously reported risk factors, such as hyperten-
occurred more frequently in patients with CSCR (57.5% sion, depression, allergy, and tobacco or alcohol use, were
had ISI score >10) than it did in the control group not statistically significantly different in CSCR and control
(15%; P < .001; odds ratio [OR] [95% confidence interval]: groups (Table 1).
7.6 [2.721.7]; Table 1). Moreover, the mean of the ISI
score (6 SD) was significantly higher in the CSCR group
MULTIVARIATE LOGISTIC REGRESSION
(9.6 6 6.2) than in the control group (4.1 6 4.5; ANALYSIS: A stepwise logistic regression confirmed the
P < .001; Figure). We also examined the relationship following risk factors (Table 2): shift work (P .02; OR:
between CSCR type and sleep disorders, which were 5 [1.220.4]), corticosteroid use (P .03; OR: 5.5
more frequently observed in cases of chronic CSCR [1.126.2]), and recent psychological stress (P < .001;
(78.6% had ISI score >10) than in acute CSCR (46.1%; OR: 15.3 [4.154.5]).
P < .05).
Seventeen CSCR patients (42.5%) had performed shift
work, vs 6 patients (15%) in the control group (P .007;
OR: 4.6 [1.511.9], Table 1). Shift workers had a higher
ISI score than day workers (ISI mean 6 SD, shift workers: DISCUSSION
10.9 6 5.5 vs day workers: 5.2 6 5.5; P < .001).
Previously reported risk factors were also analyzed. IN THIS STUDY, SHIFT WORK AND SLEEP DISTURBANCE WERE
Corticosteroid use was present or reported in the reported significantly more frequently in CSCR patients
3 months before the first CSCR symptoms in 15 patients than in matched control individuals. Shift work was re-
(37.5%) of the CSCR group and 4 patients (10%) in the ported by 15% of individuals in the control group, consis-
control group (P .007; OR: 5.4 [1.717.3], Table 1). tent with the percentage of shift workers in the
Among the 15 CSCR patients, use of corticosteroids industrialized countries.14 However, in the CRSC patients
was topical skin application in 5 patients (33.3%), intra- this was elevated to 42.5%. We can speculate that shift
nasal administration in 4 patients (26.7%), oral medica- work could affect the course and the severity of CSCR.
tion in 4 patients (26.7%), intravenous injection in Indeed, sleep disturbances were found more frequently in
1 patient (6.7%), and intramuscular injection in 1 pa- chronic CSCR than in the acute form. In our study data,
tient (6.7%). In the control group, among the 4 patients shift workers had a higher ISI score than day workers;
reporting corticosteroid use, 2 reported eye drop, this agrees well with previous studies, which reported a
1 topical skin application, and 1 oral corticosteroid strong association between shift work and sleep distur-
administration. bance.15,24,25

VOL. 165 SHIFT WORK AND CENTRAL SEROUS CHORIORETINOPATHY 25

 29% of patients had elevated single morning plasma cate-
TABLE 2. Multivariate Adjusted Risk Factors for Central cholamine levels. These observations support the potential
Serous Chorioretinopathy involvement of corticosteroid and possibly cathecholamine
metabolism deregulation in the pathogenesis of CSCR.
Exposure Odds Ratio 95% Confidence Interval P Value
Melatonin, a major marker of biological-clock activity,32
Shift work, n (%) 5 1.220.4 .02 is secreted by the pineal gland with a marked circadian
Steroid use, n (%) 5.5 1.126.2 .03 rhythm, peaking at night for a duration directly related to
Stress, n (%) 15.3 4.154.5 <.001 the length of the night.33 Melatonin production is
suppressed by light through melanopsin ganglion cell acti-
In large epidemiologic studies, shift work has been recog- vation in the retina during daylight, explaining the lower
nized as a risk factor for cardiovascular diseases, diabetes, level of melatonin detected in shift workers exposed to
obesity, depression, and certain types of cancers, raising light during night time.13,34 Melatonin rhythm and levels
public health concerns.13 Circadian disruption resulting have not been explored in CSCR patients. But a recent
from shift work may act as a pathogenic factor,14 enhancing study, although in a limited number of patients, showed
the activity of neuroendocrine and pro-oxidative systems potential beneficial effect of oral melatonin in patients
and reducing immune defenses. Several studies have with nonresolving CSCR.35
assessed the impact of shift work schedules on stress Although prospective and controlled, this study still has
hormone rhythms and levels. In particular, cortisol and cat- limitations. Sleep disturbance, evaluated by the ISI ques-
echolamines are controlled by circadian regulation, the tionnaire, was significantly more frequent in CSCR
sleep/wake cycle,26 light exposure conditions,27 and the patients, and even more so in patients with chronic
pattern of activity.28 Cortisol follows a strict diurnal CSCR, than in matched control subjects. While shift
rhythm, with peak levels in the early morning and lower work is a recognized cause of sleep disturbance, a full anal-
levels in the evening and night periods. Plasma epineph- ysis of sleep disturbance mechanisms was not undertaken in
rine and norepinephrine levels, markers of sympathetic this study. Other reasons for sleep disturbance were previ-
nervous activity, exhibit endogenous circadian rhyth- ously identified in CSCR patients, such as anxiety36 and
micity, with a maximum release during the middle of the obstructive sleep apnea (with contradictory results
day and minimum release during the night.16 Both cortisol reported).37,38 Sleep disturbance is multifactorial and
and catecholamine rhythms can thus be deregulated in impossible to separate fully from the other contributing
shift workers and therefore may contribute to the CSCR factors. Another weakness is the subjective assessment of
pathophysiology. sleep with a questionnaire scoring as compared to the
Indeed, the role of corticosteroid and possibly catechol- objectivity of polysomnography. However, the ISI
amines has previously been recognized in the pathophysi- questionnaire has been shown to correlate well with
ology of CSCR.3 Many of the described risk factors, such polysomnography, indicating that ISI is a useful and a
as therapeutic corticosteroid use, psychological stress, simple tool to quantify perceived insomnia severity.39
type A personality, and pregnancy, are conditions associ- The sample size, although relatively small, allowed
ated with alteration of glucocorticoid metabolism.29 recognition of the 2 main identified risk factors: corticoste-
CSCR develops in up to 5% of patients with endogenous roid intake and stress. Importantly, a significant association
Cushing syndrome.30,31 The metabolism of systemic and was identified between shift work and CSCR. Shift work
ocular corticosteroids in CSCR patients as compared to may be an independent risk factor for CSCR patients,
matched controls has not yet been fully analyzed. But and further research should be undertaken to confirm these
several studies have documented that 8 AM and 11 PM preliminary results. Workday reconfiguration should be
serum cortisol levels and total 24-hour urine cortisol levels considered as part of the therapeutic scheme of patients
were significantly higher in acute CSCR patients than in with chronic and/or recurrent CSCR. If confirmed,
controls.19 Another study29 demonstrated that 50% of CSCR could be added to the long list of shift workassoci-
CSCR patients had elevated 24-hour urine cortisol and ated diseases.

FUNDING/SUPPORT: THIS WORK WAS SUPPORTED BY GRANTS FROM THE FONDATION VISIO. FINANCIAL DISCLOSURES: THE
following authors have no financial disclosures: Elodie Bousquet, Myriam Dhundass, Mathieu Lehmann, Pierre-Raphael Rothschild, Virginie Bayon,
Damien Leger, Ciara Bergin, Ali Dirani, Talal Beydoun, and Francine Behar-Cohen. All authors attest that they meet the current ICMJE criteria for
authorship.

26 AMERICAN JOURNAL OF OPHTHALMOLOGY MAY 2016

 REFERENCES 17. Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia
Severity Index: psychometric indicators to detect insomnia
1. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. cases and evaluate treatment response. Sleep 2011;34(5):
The incidence of central serous chorioretinopathy in Olmsted 601608.
County, Minnesota, 1980-2002. Ophthalmology 2008;115(1): 18. Meerlo P, Sgoifo A, Suchecki D. Restricted and disrupted
169173. sleep: effects on autonomic function, neuroendocrine stress
2. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced systems and stress responsivity. Sleep Med Rev 2008;12(3):
depth imaging optical coherence tomography of the choroid 197210.
in central serous chorioretinopathy. Retina 2009;29(10): 19. Garg SP, Dada T, Talwar D, Biswas NR. Endogenous cortisol
14691473. profile in patients with central serous chorioretinopathy. Br
3. Daruich A, Matet A, Dirani A, et al. Central serous chorior- J Ophthalmol 1997;81(11):962964.
etinopathy: recent findings and new physiopathology hypoth- 20. Kapetanios AD, Donati G, Bouzas E, Mastorakos G,
esis. Prog Retin Eye Res 2015;48:82118. Pournaras CJ. [Serous central chorioretinopathy and endoge-
4. Tittl MK, Spaide RF, Wong D, et al. Systemic findings asso- nous hypercortisolemia]. Klin Monatsblatter Fur Augenheilkd
ciated with central serous chorioretinopathy. Am J Ophthal- 1998;212(5):343344.
mol 1999;128(1):6368. 21. Sun J, Tan J, Wang Z, Yang H, Zhu X, Li L. Effect of catechol-
5. Bouzas EA, Karadimas P, Pournaras CJ. Central serous amine on central serous chorioretinopathy. J Huazhong Univ
chorioretinopathy and glucocorticoids. Surv Ophthalmol Sci Technolog Med Sci 2003;23(3):313316.
2002;47(5):431448. 22. Nicholson B, Noble J, Forooghian F, Meyerle C. Central
6. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk serous chorioretinopathy: update on pathophysiology and
factors for central serous chorioretinopathy: a case-control treatment. Surv Ophthalmol 2013;58(2):103126.
study. Ophthalmology 2004;111(2):244249. 23. Bastien CH, Vallieres A, Morin CM. Validation of the
7. Tewari HK, Gadia R, Kumar D, Venkatesh P, Garg SP. Sym- Insomnia Severity Index as an outcome measure for insomnia
pathetic-parasympathetic activity and reactivity in central research. Sleep Med 2001;2(4):297307.
serous chorioretinopathy: a case-control study. Invest Ophthal- 24. De Martino MM, Abreu AC, Barbosa MF, Teixeira JE. The
mol Vis Sci 2006;47(8):34743478. relationship between shift work and sleep patterns in nurses.
8. Michael JC, Pak J, Pulido J, de Venecia G. Central serous Cienc Saude Coletiva 2013;18(3):763768.
chorioretinopathy associated with administration of sympa- 25. Lin P-C, Chen C-H, Pan S-M, et al. Atypical work schedules
thomimetic agents. Am J Ophthalmol 2003;136(1):182185. are associated with poor sleep quality and mental health in
9. Gelber GS, Schatz H. Loss of vision due to central serous Taiwan female nurses. Int Arch Occup Environ Health 2012;
chorioretinopathy following psychological stress. Am J Psychi- 85(8):877884.
atry 1987;144(1):4650. 26. Goichot B, Weibel L, Chapotot F, Gronfier C, Piquard F,
10. Yannuzzi LA. Type-A behavior and central serous choriore- Brandenberger G. Effect of the shift of the sleep-wake cycle
tinopathy. Retina 1987;7(2):111131. on three robust endocrine markers of the circadian clock.
11. Carlesimo SC, Piazzi G, Leone C, Di Santo L, Coccanari de Am J Physiol 1998;275(2 Pt 1):E243E248.
Fornari MA. [Masudas Central Serous Chorioretinopathy 27. Scheer FA, Buijs RM. Light affects morning salivary cortisol
(C.S.C.R.) and its somatic investment in Narcissism: our in humans. J Clin Endocrinol Metab 1999;84(9):33953398.
observations on new psychiatric nosography]. Clin Ter 28. Kanaley JA, Weltman JY, Pieper KS, Weltman A,
2014;165(1):2730 [in Italian]. Hartman ML. Cortisol and growth hormone responses to ex-
12. Chen S-N, Lian I, Chen Y-C, Ho J-D. Increased incidence of ercise at different times of day. J Clin Endocrinol Metab 2001;
peptic ulcer disease in central serous chorioretinopathy pa- 86(6):28812889.
tients: a population-based retrospective cohort study. Retina 29. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in
2015;35(2):231237. patients with central serous chorioretinopathy. Ophthal-
13. Faraut B, Bayon V, Leger D. Neuroendocrine, immune and mology 2003;110(4):698703.
oxidative stress in shift workers. Sleep Med Rev 2013;17(6): 30. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-
433444. Kupfer MI. Central serous chorioretinopathy in endogenous
14. Wright KP, Bogan RK, Wyatt JK. Shift work and the assess- hypercortisolism. Arch Ophthalmol 1993;111(9):12291233.
ment and management of shift work disorder (SWD). Sleep 31. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corti-
Med Rev 2013;17(1):4154. costeroids and central serous chorioretinopathy. Ophthal-
15. Lajoie P, Aronson KJ, Day A, Tranmer J. A cross-sectional mology 2002;109(10):18341837.
study of shift work, sleep quality and cardiometabolic risk 32. Rajaratnam SM, Arendt J. Health in a 24-h society. Lancet
in female hospital employees. BMJ Open 2015;5(3): 2001;358(9286):9991005.
e007327. 33. Arendt J. Shift work: coping with the biological clock. Occup
16. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse Med (Lond) 2010;60(1):1020.
metabolic and cardiovascular consequences of circadian 34. Bhatti P, Mirick DK, Davis S. Racial differences in the asso-
misalignment. Proc Natl Acad Sci U S A 2009;106(11): ciation between night shift work and melatonin levels among
44534458. women. Am J Epidemiol 2013;177(5):388393.

VOL. 165 SHIFT WORK AND CENTRAL SEROUS CHORIORETINOPATHY 27

35. Gramajo AL, Marquez GE, Torres VE, et al. Therapeutic 37. Yavas GF, Kusbeci T, Kasikci M, et al. Obstructive sleep
benefit of melatonin in refractory central serous chorioretin- apnea in patients with central serous chorioretinopathy.
opathy. Eye (Lond) 2015;29(8):10361045. Curr Eye Res 2014;39(1):8892.
36. Bazzazi N, Ahmadpanah M, Akbarzadeh S, Seif 38. Brodie FL, Charlson ES, Aleman TS, et al. Obstructive sleep
Rabiei MA, Holsboer-Trachsler E, Brand S. In patients apnea and central serous chorioretinopathy. Retina 2015;
suffering from idiopathic central serous chorioretinopathy, 35(2):238243.
anxiety scores are higher than in healthy controls, but do 39. Sadeghniiat-Haghighi K, Yazdi Z, Firoozeh M. Comparison of
not vary according to sex or repeated central serous two assessment tools that measure insomnia: the insomnia
chorioretinopathy. Neuropsychiatr Dis Treat 2015;11: severity index and polysomnography. Indian J Psychol Med
11311136. 2014;36(1):5457.

28 AMERICAN JOURNAL OF OPHTHALMOLOGY MAY 2016

Reproduced with permission of the copyright owner. Further reproduction prohibited without
permission.